We are live on ! Find out more
PROF

Profound Medical

57 hedge funds and large institutions have $106M invested in Profound Medical in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.38% less ownership

Funds ownership: 45.4%45.02% (-0.38%)

10% less funds holding

Funds holding: 6357 (-6)

16% less capital invested

Capital invested by funds: $126M → $106M (-$20.7M)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

70% less call options, than puts

Call options by funds: $140K | Put options by funds: $467K

Holders
57
Holders Change
-6
Holders Change %
-9.52%
% of All Funds
0.7%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
10
Increased
21
Reduced
7
Closed
16
Calls
$140K
Puts
$467K
Net Calls
-$327K
Net Calls Change
-$327K
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Perkins Capital Management
Minnesota
$741K
TC
27
T3 Companies
New York
$702K +$417K +60,340 +126%
UBS Group
28
UBS Group
Switzerland
$526K +$522K +75,603 +1,373%
Truist Financial
29
Truist Financial
North Carolina
$324K
AGWCA
30
Annis Gardner Whiting Capital Advisors
Florida
$259K +$276K +40,000 New
NEI
31
Northwest & Ethical Investments
Ontario, Canada
$244K
Simplex Trading
32
Simplex Trading
Illinois
$238K +$250K +36,121 +6,050%
Jane Street
33
Jane Street
New York
$238K +$253K +36,687 New
HWM
34
HB Wealth Management
Georgia
$194K +$207K +30,000 New
CC
35
Centiva Capital
New York
$190K +$202K +29,280 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$138K +$50.4K +7,297 +52%
Goldman Sachs
37
Goldman Sachs
New York
$121K -$138 -20 -0.1%
Focus Partners Wealth
38
Focus Partners Wealth
Massachusetts
$108K
MIM
39
MTM Investment Management
South Carolina
$105K -$4.14K -600 -4%
PM
40
Penbrook Management
New York
$79.7K +$85K +12,300 New
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$75.1K
CAPTRUST Financial Advisors
42
CAPTRUST Financial Advisors
North Carolina
$67.4K +$71.8K +10,398 New
PCM
43
PenderFund Capital Management
British Columbia, Canada
$60.1K
Rockefeller Capital Management
44
Rockefeller Capital Management
New York
$43.1K
Wells Fargo
45
Wells Fargo
California
$36.2K +$4.14K +600 +12%
BlackRock
46
BlackRock
New York
$30.3K
Osaic Holdings
47
Osaic Holdings
Arizona
$19.9K +$20.7K +3,000 +4,000%
MA
48
MCF Advisors
Kentucky
$13K
SWA
49
SOA Wealth Advisors
New York
$13K
Morgan Stanley
50
Morgan Stanley
New York
$12.5K

PROF Hedge Fund Activity: Q1 2026 in Review

57 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2026, worth a combined $106M — down 16% from $126M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of PROF and 10 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 21 added.

The largest buyer was Lagoda Investment Management, opening a new position worth an estimated $3.05M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.34M sold.

  • 57 institutional investors held Profound Medical (PROF) as of Q1 2026, down from 63 in Q4 2025.
  • Funds reported $106M of Profound Medical stock for Q1 2026, down 16% quarter-over-quarter.
  • 10 funds opened new Profound Medical positions in Q1 2026 and 16 closed out, a net change of -6 holders.
  • The largest Profound Medical buyer in Q1 2026 was Lagoda Investment Management, an estimated $3.05M added.
  • The largest Profound Medical seller in Q1 2026 was Alyeska Investment Group, an estimated $5.34M sold.

Based on aggregated 13F filings for Q1 2026.